Rising Malaria Deaths Amid Funding Cuts and Drug Resistance

According to the World Health Organization (WHO), malaria deaths rose to approximately 610,000 in 2024, primarily affecting young children in sub-Saharan Africa. This figure represents a slight increase from the previous year, with malaria cases also rising from 273 million to an estimated 282 million. The WHO's annual malaria report highlights that while 47 countries have been certified malaria-free, nations such as Ethiopia, Madagascar, and Yemen are experiencing significant increases in cases. Daniel Ngamije Madandi, director of the WHO’s global malaria programme, emphasized that “too many people are still dying from a preventable and curable disease.”

ReutersEuronewsMeasles deaths fall 88% since 2000, but global cases surge — WHOGlobal Measles Cases Surge as Vaccination Rates Fall, WHO Warns

The WHO attributes the uptick in malaria cases and deaths to several factors, including rising drug resistance, climate change, and ongoing conflicts. The report indicates that the incidence of malaria has increased from 59 to 64 cases per 100,000 people at risk between 2015 and 2024. Despite a slight decline in mortality rates from 14.9 to 13.8 per 100,000 people at risk, the overall situation remains dire. Funding for malaria control has consistently fallen short, with total investments reaching only $3.9 billion in 2024, significantly below the required $9 billion.

ReutersEuronewsMeasles deaths fall 88% since 2000, but global cases surge — WHO

The WHO warns that recent cuts in international aid, particularly from wealthy nations like the United States, the United Kingdom, Germany, and France, exacerbate the challenges in combating malaria. Gareth Jenkins, managing director of the nonprofit Malaria No More UK, noted that the funding reductions raise the risk of outbreaks and a potential resurgence of malaria. He called for increased global funding for new treatments, next-generation bed nets, and vaccination campaigns, stressing the need for leaders to recognize the scale of the malaria crisis.

EuronewsReutersGlobal Measles Cases Surge as Vaccination Rates Fall, WHO Warns

Critics argue that the current response to malaria is insufficient, particularly in light of the funding cuts and the growing threat of drug resistance. The WHO has reported partial resistance to artemisinin, a key malaria treatment, in at least eight African countries. This resistance complicates efforts to control the disease, which is already challenging due to its transmission through mosquitoes. Jenkins highlighted the urgent need for enhanced funding and innovative solutions to address these escalating challenges.

Euronews

• “Too many people are still dying from a preventable and curable disease,” — Daniel Ngamije Madandi, Director, WHO Global Malaria Programme

Reuters

• “We need leaders not only to understand the scale of a possible malaria resurgence, but to see the potential of malaria science to help countries fight back,” — Gareth Jenkins, Managing Director, Malaria No More UK

Euronews

The WHO's report underscores the critical need for renewed commitment and investment in malaria control efforts. As the disease continues to pose a significant public health challenge, addressing funding shortfalls and enhancing treatment options will be essential to reversing the current trends in malaria morbidity and mortality.

Euronews